In vitro metabolomic approaches to investigating the potential biological effects of phenolic compounds: an update
| dc.audience.educationLevel | ||
| dc.contributor.author | Catalán Santos, Úrsula | |
| dc.contributor.author | Barrubés Piñol, Laura | |
| dc.contributor.author | Maria Valls, Rosa | |
| dc.contributor.author | Solà, Rosa | |
| dc.contributor.author | Rubió Piqué, Laura | |
| dc.date.accessioned | 2017-06-26T08:23:50Z | |
| dc.date.available | 2017-06-26T08:23:50Z | |
| dc.date.issued | 2017 | |
| dc.description.abstract | Dietary phenolic compounds (PCs) have been receiving interest for their presumed roles in disease prevention. However, there is a lack of studies on the underlying molecular mechanisms. In this regard, in vitro metabolomic approaches are suitable for the investigation of the molecular changes in response to PC exposure. Up to date, the biological effects of PCs have only been examined for PCs from rosemary (Rosmarinus officinalis), olive oil, and resveratrol using cell-based metabolomic approach, although transcriptomic and/or proteomic studies have also been conducted in the same in vitro cell experiment in some cases. Our integral analysis of the reviewed studies suggest that PCs may be involved not only in basic cellular processes or macro- and micro-nutrient metabolism, but also in specific metabolic pathways that have been thoroughly investigated. These modulated pathways could have a clinical impact on neurodegenerative diseases, type 2 diabetes, cancer, and cardiovascular diseases. In conclusion, the in vitro metabolomic approaches provide additional information of the molecular mechanisms involved in disease risk reduction of dietary PCs. In order to elucidate the mechanisms of action of PCs, more metabolomic cell-based studies are needed and testing the physiological conjugated forms of PCs in these cell systems could be of special interest. | ca_ES |
| dc.description.sponsorship | This work was partially supported by grants (Grant Nos. AGL2009-13517-C03-03 and AGL2012-40144-C03-02) from the Spanish Ministry of Education and Science (Ministerio de Educación y Ciencia, Spain), a Sara Borrell post-doctoral grant (CD14/00275; Spain), a Pla estratègic de recerca i innovació en salut (PERIS) post-doctoral grant (SLT002/16/00239; Catalunya, Spain). We also thank the support of Institut d’Investigació Sanitària Pere Virgili (IISPV) and Centre Tecnològic de Nutrició i Salut (CTNS), Reus, Spain. NFOC-Salut group is a consolidated research group of Generalitat de Catalunya, Spain (2014 SGR 873) | ca_ES |
| dc.identifier.doi | https://doi.org/10.1016/j.gpb.2016.12.007 | |
| dc.identifier.idgrec | 030918 | |
| dc.identifier.issn | 1672-0229 | |
| dc.identifier.uri | http://hdl.handle.net/10459.1/59935 | |
| dc.language.iso | eng | ca_ES |
| dc.publisher | Elsevier | ca_ES |
| dc.relation | info:eu-repo/grantAgreement/MICINN//AGL2009-13517-C03-03/ES/Aceite De Oliva Virgen Y Funcionalidad De La Hdl: Un Modelo De Preparacion Especializada De Un Alimento Funcional/ | |
| dc.relation | info:eu-repo/grantAgreement/MINECO//AGL2012-40144-C03-02/ES/DIANAS METABOLICAS DE LOS COMPUESTOS FENOLICOS DEL ACEITE DE OLIVA: ESTUDIO DE LA SEÑALIZACION CELULAR Y DE LA PROTEOMICA/ | |
| dc.relation.isformatof | Reproducció del document publicat a https://doi.org/10.1016/j.gpb.2016.12.007 | ca_ES |
| dc.relation.ispartof | Genomics Proteomics Bioinformatics, 2017, vol. 15, núm. 4, p. 236-245 | ca_ES |
| dc.rights | cc-by (c) Barrubés et al., 2017 | ca_ES |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | ca_ES |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
| dc.subject | Cell-based | ca_ES |
| dc.subject | Metabolomics | ca_ES |
| dc.subject | Phenolic compounds | ca_ES |
| dc.subject | Mechanism of action | ca_ES |
| dc.subject | Disease prevention | ca_ES |
| dc.title | In vitro metabolomic approaches to investigating the potential biological effects of phenolic compounds: an update | ca_ES |
| dc.type | article | ca_ES |
| dc.type.version | publishedVersion | ca_ES |